Penetrium Bioscience Amends Capital Increase Schedule
페니트리움바이오
187660
Signal Score
Historical Avg Return (5d)
+0.38%
Data Coverage
100%n=2330
Risk-adjusted indicator based on 2330 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • New Share Allotment Record Date: June 30, 2026 (Changed from June 16, 2026)
- • Old Shareholder Subscription Period: August 5-6, 2026 (Changed from July 22-23, 2026)
- • General Public Offering Period: August 10-11, 2026 (Changed from July 27-28, 2026)
- • New Share Allotment Ratio: 0.1551578144 shares per existing share
- • Discount Rate for Issuance Price: 25%
AI Analysis Summary
Penetrium Bioscience Inc. has amended its Material Fact Report regarding a paid-in capital increase. The key changes involve the postponement of the new share allotment record date to June 30, 2026, and the old shareholder subscription period to August 5-6, 2026. The general public offering period is also moved to August 10-11, 2026. The issuance price will be determined with a 25% discount rate, and existing shareholders will receive 0.1551578144 new shares per existing share. While the capital increase itself is dilutive, this amendment primarily concerns schedule adjustments, leading to a neutral financial impact in the short term, though the overall dilution remains a factor.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.